Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV open-label study of stiripentol suspension added to clobazam and valproate for Dravet syndrome
CTR20250115Phase 4Active
- Sponsor
- Shijiazhuang No. 4 Pharmaceutical
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of stiripentol in Dravet syndrome, sponsored by Shijiazhuang No. 4 Pharmaceutical. Started Jan 2025; status: active.
02
Drugs
stiripentol
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on CTR20250115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250115.